Applied Therapeutics APLT 深 滬
等待開盤 11-26 09:30:00 美东时间
0.2491
-0.009
-3.56%
華盛通- 最 高0.2612
- 今 開0.26
- 成交量 530.37万股
- 最 低 0.241
- 昨 收 0.2583
- 總市值 3587.04万
- 52周最高 1.50
- 市盈率 靜 --
- 換手率 3.68%
- 52周最低 0.2182
- 委 比 -50.00%
- 總股本 1.44亿
- 歷史最高 57.39
- 量 比 0.38
- 振 幅 7.82%
- 歷史最低 0.2182
- 每 手 1
- 風險率 1.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Applied Therapeutics Announces Strategic Review and Workforce Cuts
An announcement from Applied Therapeutics ( ($APLT) ) is now available. On Nove...
11-20 21:28
Applied Therapeutics Announces Corporate Updates
Applied Therapeutics, a clinical-stage biopharmaceutical company, announced it has initiated a process to explore strategic alternatives to maximize shareholder value, which may include mergers, acquisitions, partnerships, or other transactions. The company is also reducing its workforce by approximately 46% to conserve cash. The Board remains committed to acting in the best interests of all stockholders. Additionally, the company is engaging wit...
11-20 12:00
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Mersana Therapeutics (NASDAQ:MRSN) stock increased by 205.0% to $27.05...
11-14 01:06
Applied Therapeutics shares are trading lower. The company reported Q3 financial results.
Applied Therapeutics shares are trading lower. The company reported Q3 financia...
11-13 22:05
Applied Therapeutics Q3 EPS $(0.13) Beats $(0.14) Estimate, Sales $1.000M
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 8.45 percent. This is a 72.92 percent increase over losses of $(0.48) per share
11-13 20:18
4 Biotech Stocks Seeing Explosive Momentum Gains
The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here's a look at several momentum standouts in the biotech space that appear to be rapidly gaining strength.
10-07 23:19
美股牛股 | TSHA飙升超53%，试验性治疗获FDA突破性疗法认定；嘉楠科技大涨近27%
TSHA飙升超53%，试验性治疗获FDA突破性疗法认定；嘉楠科技大涨近27%，比特币重返12万美元叠加公司获得大规模矿机订单；ONDS涨26%，获国防无人机订单>>
10-03 19:10
Applied Therapeutics Meets With FDA On Potential Drug Filing For Rare Nerve Disease CMT-SORD
Applied Therapeutics, Inc. (NASDAQ: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company completed a meeting with the U.S.
09-29 19:34
Applied Therapeutics Provides Update Following Meeting with FDA
Applied Therapeutics Inc. (APLT) held a meeting with the FDA to discuss the potential NDA submission for govorestat to treat Charcot-Marie-Tooth Sorbitol Dehydrogenase (SORD) Deficiency (CMT-SORD). The company is awaiting FDA meeting minutes to determine next steps, with no final submission strategy or accelerated approval pathway decided yet. CMT-SORD is a rare, progressive neuropathy affecting approximately 3,300 patients in the U.S. and 4,000 ...
09-29 11:00
纳斯达克生物科技指数收涨将近1.5%
成分股Applied Therapeutics收涨119.56%，Crinetics Pharma涨27.92%，Annexon涨20.79%表现第三。Kyv...
09-27 04:30
